184 related articles for article (PubMed ID: 16361740)
41. Topical photodynamic therapy for dermatologic disorders: results and complications.
Redbord KP; Hanke CW
J Drugs Dermatol; 2007 Dec; 6(12):1197-202. PubMed ID: 18189059
[TBL] [Abstract][Full Text] [Related]
42. Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid 0.5% liposomal spray and intense pulsed light in combination with topical keratolytic agents.
de Leeuw J; van der Beek N; Bjerring P; Neumann HA
J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):460-9. PubMed ID: 19796088
[TBL] [Abstract][Full Text] [Related]
43. A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lamp.
Reinhold U; Dirschka T; Ostendorf R; Aschoff R; Berking C; Philipp-Dormston WG; Hahn S; Lau K; Jäger A; Schmitz B; Lübbert H; Szeimies RM
Br J Dermatol; 2016 Oct; 175(4):696-705. PubMed ID: 26921093
[TBL] [Abstract][Full Text] [Related]
44. Effect of retinoid pretreatment on outcomes of patients treated by photodynamic therapy for actinic keratosis of the hand and forearm.
Galitzer BI
J Drugs Dermatol; 2011 Oct; 10(10):1124-32. PubMed ID: 21968662
[TBL] [Abstract][Full Text] [Related]
45. Photosensitization induced by exposure to colour cathode ray tube monitor following topical 5-aminolaevulinic acid-based photodynamic therapy: a case report.
Wang X; Wang H; Huang Z
Acta Derm Venereol; 2010 Sep; 90(5):545-7. PubMed ID: 20814646
[No Abstract] [Full Text] [Related]
46. The influence of the vehicle on the synthesis of porphyrins after topical application of 5-aminolaevulinic acid. Implications in cutaneous photodynamic sensitization.
Casas A; Fukuda H; Di Venosa G; Batlle AM
Br J Dermatol; 2000 Sep; 143(3):564-72. PubMed ID: 10971330
[TBL] [Abstract][Full Text] [Related]
47. Immediate whealing urticaria in red light exposed areas during photodynamic therapy.
Kaae J; Philipsen PA; Haedersdal M; Wulf HC
Acta Derm Venereol; 2008; 88(5):480-3. PubMed ID: 18779886
[TBL] [Abstract][Full Text] [Related]
48. Photodynamic therapy with topical 5-aminolevulinic acid for mycosis fungoides: clinical and histological response.
Edström DW; Porwit A; Ros AM
Acta Derm Venereol; 2001; 81(3):184-8. PubMed ID: 11558874
[TBL] [Abstract][Full Text] [Related]
49. Pain associated with aminolevulinic acid-photodynamic therapy of skin disease.
Warren CB; Karai LJ; Vidimos A; Maytin EV
J Am Acad Dermatol; 2009 Dec; 61(6):1033-43. PubMed ID: 19925929
[TBL] [Abstract][Full Text] [Related]
50. Topical photodynamic therapy in dermatology.
Szeimies RM; Calzavara-Pinton P; Karrer S; Ortel B; Landthaler M
J Photochem Photobiol B; 1996 Nov; 36(2):213-9. PubMed ID: 9002264
[TBL] [Abstract][Full Text] [Related]
51. Influence of topical photodynamic therapy with 5-aminolevulinic acid on porphyrin metabolism.
Fritsch C; Verwohlt B; Bolsen K; Ruzicka T; Goerz G
Arch Dermatol Res; 1996 Aug; 288(9):517-21. PubMed ID: 8874745
[TBL] [Abstract][Full Text] [Related]
52. Photodynamic therapy using topically applied hypericin: comparative effect with methyl-aminolevulinic acid on UV induced skin tumours.
Boiy A; Roelandts R; de Witte PA
J Photochem Photobiol B; 2011 Feb; 102(2):123-31. PubMed ID: 21035351
[TBL] [Abstract][Full Text] [Related]
53. Large surface photodynamic therapy with aminolevulinic acid: treatment of actinic keratoses and beyond.
Bissonette R; Bergeron A; Liu Y
J Drugs Dermatol; 2004; 3(1 Suppl):S26-31. PubMed ID: 14964758
[TBL] [Abstract][Full Text] [Related]
54. [Plaque-phase mycosis fungoides treated with photodynamic therapy: results from 12 patients].
Fernández-Guarino M; Harto A; Pérez-García B; Montull C; De Las Heras E; Jaén P
Actas Dermosifiliogr; 2010 Nov; 101(9):785-91. PubMed ID: 21034709
[TBL] [Abstract][Full Text] [Related]
55. Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.
Berman B; Nestor MS; Newburger J; Park H; Swenson N
J Drugs Dermatol; 2014 Nov; 13(11):1353-6. PubMed ID: 25607702
[TBL] [Abstract][Full Text] [Related]
56. Topical photodynamic therapy of actinic keratoses with 5-aminolevulinic acid: randomized controlled trial with six months follow-up.
Buinauskaite E; Maciulaitis R; Buinauskiene J; Valiukeviciene S
J Dermatolog Treat; 2014 Dec; 25(6):519-22. PubMed ID: 24215475
[TBL] [Abstract][Full Text] [Related]
57. Photodynamic therapy with methylaminolevulinate as a valuable treatment option for unilesional cutaneous T-cell lymphoma.
Zane C; Venturini M; Sala R; Calzavara-Pinton P
Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):254-8. PubMed ID: 16948827
[TBL] [Abstract][Full Text] [Related]
58. Photodynamic therapy as an alternative treatment for mycosis fungoides: a systemic review and meta-analysis.
Seyed Jafari SM; Cazzaniga S; Hunger RE
G Ital Dermatol Venereol; 2018 Dec; 153(6):827-832. PubMed ID: 29683282
[TBL] [Abstract][Full Text] [Related]
59. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group.
Morton CA; Brown SB; Collins S; Ibbotson S; Jenkinson H; Kurwa H; Langmack K; McKenna K; Moseley H; Pearse AD; Stringer M; Taylor DK; Wong G; Rhodes LE
Br J Dermatol; 2002 Apr; 146(4):552-67. PubMed ID: 11966684
[TBL] [Abstract][Full Text] [Related]
60. Urticaria-like reaction secondary to photodynamic therapy in 2 pediatric patients.
Miguélez A; Martín-Santiago A; Bauzá A; Gilaberte Y
Actas Dermosifiliogr; 2013 Oct; 104(8):727-9. PubMed ID: 23954045
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
